An Open Label Randomized Phase I/II Trial of MLN0128 Compared to Sorafenib in Patients With Advanced or Metastatic Hepatocellular Carcinoma: Big Ten Cancer Research Consortium BTCRC-GI13-002

Status: Terminated

Learn more:

• clinicaltrials.gov: #NCT02575339
• See Study Information on Big Ten CRC Website